Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Cannon

Showing results (61-70 of 149) with videos related to

Pageof 15
Sort By:
Journal of the American College of Cardiology|February 14, 1998
Time to positivity of a rapid bedside assay for cardiac-specific troponin T predicts prognosis in acute coronary syndromes: a Thrombolysis in Myocardial Infarction (TIMI) 11A substudyE M Antman, D B Sacks, N Rifai, et al.
The American Journal of Cardiology|October 7, 1998
Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 Trial. Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy. Thrombolysis In Myocardial InfarctionC P Cannon, W S Weintraub, L A Demopoulos, et al.
The American Journal of Cardiology|November 13, 2001
Seasonal variation of myocardial infarct sizeR A Kloner, S Das, W K Poole, et al.
Chest|February 7, 2001
Intravenous thrombolysis in acute myocardial infarctionE M Ohman, R A Harrington, C P Cannon, et al.
Clinical Cardiology|February 4, 1999
Emergency department thrombolysis critical pathway reduces door-to-drug times in acute myocardial infarctionC P Cannon, E B Johnson, M Cermignani, et al.
European Heart Journal|February 28, 2002
Oral glycoprotein IIb/IIIa receptor inhibitors in patients with cardiovascular disease: why were the results so unfavourableF W G Leebeek, E Boersma, C P Cannon, et al.
Archives of Internal Medicine|March 20, 2001
New approaches to diagnosis and management of unstable angina and non-ST-segment elevation myocardial infarctionR A O'Rourke, J S Hochman, M C Cohen, et al.
Clinical Orthopaedics and Related Research|April 17, 2001
Soft tissue echinococcosis: a report of two cases and review of the literatureC P Cannon, S D Nelson, C B Panosian, et al.
Diabetes, Obesity & Metabolism|September 8, 2015
Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetesR Chilton, I Tikkanen, C P Cannon, et al.
Neurology|September 2, 2009
Influence of stroke subtype on quality of care in the Get With The Guidelines-Stroke ProgramE E Smith, L Liang, A Hernandez, et al.
Pageof 15

Showing results (61-70 of 149) with videos related to

Sort By:
Pageof 15
Journal of the American College of Cardiology|February 14, 1998
Time to positivity of a rapid bedside assay for cardiac-specific troponin T predicts prognosis in acute coronary syndromes: a Thrombolysis in Myocardial Infarction (TIMI) 11A substudyE M Antman, D B Sacks, N Rifai, et al.
The American Journal of Cardiology|October 7, 1998
Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 Trial. Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy. Thrombolysis In Myocardial InfarctionC P Cannon, W S Weintraub, L A Demopoulos, et al.
The American Journal of Cardiology|November 13, 2001
Seasonal variation of myocardial infarct sizeR A Kloner, S Das, W K Poole, et al.
Chest|February 7, 2001
Intravenous thrombolysis in acute myocardial infarctionE M Ohman, R A Harrington, C P Cannon, et al.
Clinical Cardiology|February 4, 1999
Emergency department thrombolysis critical pathway reduces door-to-drug times in acute myocardial infarctionC P Cannon, E B Johnson, M Cermignani, et al.
European Heart Journal|February 28, 2002
Oral glycoprotein IIb/IIIa receptor inhibitors in patients with cardiovascular disease: why were the results so unfavourableF W G Leebeek, E Boersma, C P Cannon, et al.
Archives of Internal Medicine|March 20, 2001
New approaches to diagnosis and management of unstable angina and non-ST-segment elevation myocardial infarctionR A O'Rourke, J S Hochman, M C Cohen, et al.
Clinical Orthopaedics and Related Research|April 17, 2001
Soft tissue echinococcosis: a report of two cases and review of the literatureC P Cannon, S D Nelson, C B Panosian, et al.
Diabetes, Obesity & Metabolism|September 8, 2015
Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetesR Chilton, I Tikkanen, C P Cannon, et al.
Neurology|September 2, 2009
Influence of stroke subtype on quality of care in the Get With The Guidelines-Stroke ProgramE E Smith, L Liang, A Hernandez, et al.
Pageof 15